Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.

European journal of nuclear medicine - 1 Sept 2001

Burak Z, Ersoy O, Moretti J L, Erinç R, Ozcan Z, Dirlik A, Sabah D, Basdemir G

Abstract excerpt

The occurrence of multidrug resistance (MDR), which is in part due to the overexpression of P-glycoprotein (Pgp), is a major problem in neoadjuvant therapy of malignant musculoskeletal tumours. The aim of this study was to investigate the role of technetium-99m hexakis-2-methoxyisobutylisonitrile (99mTc-MIBI) scintigraphy for functional imaging of the MDR1 phenotype in patients with musculoskeletal sarcomas. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B, Member 1
Share to Bone Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple

Share to Neoadjuvant Therapy

Share to Osteosarcoma

Share to Radionuclide Imaging

Share to Radiopharmaceuticals

Share to Sarcoma

Source

Identifiers

PMID: 11585293
DOI: 10.1007/s002590100588

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.PMID 11585293Read ↗

Clinical imaging of multidrug resistance in cancer.Semantic proximity Read ↗

In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients.Semantic proximity Read ↗

99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.Semantic proximity Read ↗

Dynamic imaging: scintimammography.Semantic proximity Read ↗

TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?Semantic proximity Read ↗

Imaging of multidrug resistance in cancer.Semantic proximity Read ↗

Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression.Semantic proximity Read ↗

Multidrug resistance phenotype in high grade soft tissue sarcoma: correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy.Semantic proximity Read ↗

ATP‐binding cassette superfamily transporter gene expression in human soft tissue sarcomasSemantic proximity Read ↗

68Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary resultsSemantic proximity Read ↗

Influence of glioma's multidrug resistance phenotype on (99m)Tc-tetrofosmin uptake.Semantic proximity Read ↗

99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.